Michelle L Hermiston (Michelle Hermiston)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 39

Top Venues

Blood

Blood advances

Cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric Stephen Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria Luisa Sulis, Sarah Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231. Blood (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal A Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick J Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study. Blood advances (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric S Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria-Luisa Sulis, Sarah L Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood 143 (20) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal A Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick J Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study. Blood advances (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric S Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria-Luisa Sulis, Sarah L Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood 143 (20) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley P Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish K Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly J Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances 8 (9) (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric S Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria-Luisa Sulis, Sarah L Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood 143 (20) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric S Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria-Luisa Sulis, Sarah L Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231. Blood 143 (20) (2024)
Nitya Gulati, Michelle L Hermiston
Old is gold: frontline etoposide for pHLH. Blood 143 (10) (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric Stephen Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria Luisa Sulis, Sarah Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231. Blood (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric Stephen Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria Luisa Sulis, Sarah Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231. Blood (2024)
Nitya Gulati, Michelle L Hermiston
Old is gold: frontline etoposide for pHLH. Blood 143 (10) (2024)
Robert J Hayashi, Michelle L Hermiston, Brent L Wood, David Trent Teachey, Meenakshi Devidas, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Cho, Kimberly P Dunsmore, Jason Lawrence Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir Patel, Eric Stephen Schafer, Tal Schechter, Kristin A Shimano, Neelam Singh, Amii Steele, Maria Luisa Sulis, Sarah Vargas, Stuart S Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz, Catherine M Bollard, Carl E Allen
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231. Blood (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley P Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish K Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly J Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances 8 (9) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130 (14) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley P Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish K Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly J Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances 8 (9) (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley P Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish K Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly J Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances 8 (9) (2024)
Kevin Bielamowicz, Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin, Barbara Degar, Eli L Diamond, Olive S Eckstein, Nader El-Mallawany, Mark Fluchel, Gaurav Goyal, Michael M Henry, Michelle L Hermiston, Michael D Hogarty, Michael Jeng, Rima Jubran, Joseph Lubega, Ashish Kumar, Stephan Ladisch, Kenneth L McClain, Miriam Merad, Qing-Sheng Mi, D Williams Parsons, Erin Peckham-Gregory, Jennifer Picarsic, Zachary D Prudowsky, Barrett J Rollins, Peter H Shaw, Birte Wistinghausen, Carlos Rodriguez-Galindo, Carl E Allen, null null
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer (2024)
Stephanie J Si, James B Ford, Michelle L Hermiston
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood (2023)
Carol Fries, Michelle L Hermiston
Challenging T-ALL to IL-7Rp dual inhibition. Blood 142 (2) (2023)
Savannah S Shumock, William C Temple, Amanda E Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi, Alex G Lee, Stanley G Leung, E Alejandro Sweet-Cordero, Michelle L Hermiston, Christine S Higham, Elliot Stieglitz
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients. Cancer reports (Hoboken, N.J.) (2023)
David Trent Teachey, Meenakshi Devidas, Brent L Wood, Zhiguo Chen, Robert J Hayashi, Michelle L Hermiston, Robert D Annett, J Hunter Archer, Barbara L Asselin, Keith J August, Steve Y Cho, Kimberly P Dunsmore, Brian T Fisher, Jason L Freedman, Paul J Galardy, Paul Harker-Murray, Terzah M Horton, Alok I Jaju, Allison Lam, Yoav H Messinger, Rodney R Miles, Maki Okada, Samir I Patel, Eric S Schafer, Tal Schechter, Neelam Singh, Amii C Steele, Maria Luisa Sulis, Sarah L Vargas, Stuart S Winter, Charlotte Wood, Patrick Zweidler-McKay, Catherine M Bollard, Mignon L Loh, Stephen P Hunger, Elizabeth A Raetz
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Lauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, Benjamin J Huang, Dustin McMinn, Tiffaney L Vincent, Theresa Ryan, Terzah M Horton, Brent L Wood, David T Teachey, Jack Taunton, Christopher J Kirk, Michelle L Hermiston
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia. British journal of haematology 198 (1) (2022)
Liora M Schultz, Anne A Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K Keating, Christa Krupski, Holly L Pacenta, Christine L Philips, Julie-An Talano, Amy Moskop, Susanne H C Baumeister, Gary Douglas Myers, Nicole A Karras, Patrick A Brown, Muna Qayed, Michelle L Hermiston, Prakash Satwani, Rachel Wilcox, Cara A Rabik, Vanessa A Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Sharon Mavroukakis, Emily Egeler, Yimei Li, Crystal L Mackall, Kevin J Curran, Michael R Verneris, Theodore W Laetsch, Heather Stefanski
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Manh-Cong Nguyen, Vy Vuong Thao Nguyen, Hoa Le, Dinh Van Nguyen, Mai-Lan Nguyen, Michelle L Hermiston, Chi-Bao Bui, Amos Hong Pheng Loh
Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees. Pediatric blood & cancer 68 (12) (2021)
Vanessa A Fabrizio, Christine L Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly L Pacenta, Jenna Rossoff, Heather Stefanski, Julie-An An Talano, Amy Moskop, Steven P Margossian, Michael R Verneris, Gary Doug Myers, Nicole A Karras, Patrick A Brown, Muna Qayed, Michelle L Hermiston, Prakash Satwani, Christa Krupski, Amy K Keating, Rachel Wilcox, Cara A Rabik, Vasant Chinnabhandar, Michael Kunicki, A Yasemin Goksenin, Kevin J Curran, Crystal L Mackall, Theodore W Laetsch, Liora M Schultz
Tisagenlecleucel Outcomes in Relapsed/Refractory Extramedullary ALL: A Pediatric Real World CAR Consortium Report. Blood advances (2021)
Liora M Schultz, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Jenna Rossoff, Heather E Stefanski, Julie-An Talano, Amy Moskop, Steven P Margossian, Michael R Verneris, Gary Douglas Myers, Nicole A Karras, Patrick A Brown, Muna Qayed, Michelle L Hermiston, Prakash Satwani, Christa Krupski, Amy K Keating, Rachel Wilcox, Cara A Rabik, Vanessa A Fabrizio, Rayne H Rouce, Vasant Chinnabhandar, Michael Kunicki, Valentin V Barsan, A Yasemin Goksenin, Yimei Li, Sharon Mavroukakis, Emily Egeler, Kevin J Curran, Crystal L Mackall, Theodore W Laetsch
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Matthew S Zinter, Michelle L Hermiston
Calming the storm in HLH. Blood 134 (2) (2019)
Birgit Burkhardt, Michelle L Hermiston
Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities. British journal of haematology 185 (6) (2019)
Lauren K Meyer, Cristina Delgado-Martin, Shannon L Maude, Kevin M Shannon, David T Teachey, Michelle L Hermiston
CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition. PloS one 14 (7) (2019)

Michelle L Hermiston.css-eqlu8i{font-size:small;padding-left:4px;} (Michelle Hermiston)

Publication Activity (10 Years)

Top Topics

Top Venues

Michelle L Hermiston (Michelle Hermiston)